4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-013522
Chairman and CEO gave up 3,558 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2025-03-17 | Shares withheld for taxes | −3,558 | $5.17 | $18,395 | 5,698,738 | D |
| Derivatives | |||||||
| KAZIMI A J Chairman and CEO | 2025-03-17 | Grant or award · Options (right to buy) | +100,000 | $5.17 | $517,000 | 468,000 | D |
Loading xslF345X05/wk-form4_1742332139.xml…